Trials / Withdrawn
WithdrawnNCT00747071
Safety and Validation of Efficacy of Oral Administration of the Food Additive Colostrum Derived Anti Clostridium Difficile Antibodies
- Status
- Withdrawn
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical study is designed to evaluate the safety and efficacy of oral administration of the food additive colostrum derived antibodies to Clostridium difficile for prevention of Clostridium difficile associated disease (CDAD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Colostrum | Daily administration of Colostrum derived antibodies against C. difficile. |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2012-11-01
- Completion
- 2013-11-01
- First posted
- 2008-09-04
- Last updated
- 2012-08-28
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00747071. Inclusion in this directory is not an endorsement.